2005-2016 Saw No Improvement in Diabetes Care Cascade
THURDAY, Aug. 15, 2019 -- From 2005 to 2016, there was no improvement in the diabetes care cascade, according to a study published online Aug. 12 in JAMA Internal Medicine.
Pooyan Kazemian, Ph.D., from Massachusetts General Hospital in Boston, and colleagues evaluated data from the 2005 to 2016 National Health and Nutrition Examination Survey for nonpregnant U.S. adults with diabetes (1,742 diagnosed and 746 undiagnosed).
The researchers found that of the 1,742 adults with diagnosed diabetes in 2013 to 2016, 94 percent were linked to diabetes care and 23 percent achieved the composite goal for meeting all targets. In 2005-2008 and 2009-2012, the results were similar (composite goal, 23 and 25 percent, respectively). During the study period, there was no significant improvement in diagnosis or target achievement. The odds of meeting the composite target were higher for older patients (≥65 years) and lower for younger adults (18 to 44 years) versus middle-aged adults (45 to 64 years; adjusted odds ratios [aORs], 1.70 and 0.53, respectively). The odds of achieving the composite target were lower for women than men (aOR, 0.60) and for non-Hispanic black versus non-Hispanic white individuals (aOR, 0.57). The strongest predictor of linkage to care was having health insurance (aOR, 3.96).
"Despite major advances in drug discovery and movement to develop innovative diabetes care delivery models over the past two decades, the diabetes care cascade did not appear to improve," the authors write.
One author disclosed financial ties to Apolo1bio.
© 2020 HealthDay. All rights reserved.
Posted: August 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.